levodopa has been researched along with Serotonin Syndrome in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kulisevsky, J; Pagonabarraga, J | 1 |
Kaur, M; Kushwaha, S; Malhotra, HS; Panda, AK | 1 |
Chang, MC; Jang, SH; Kwon, YM | 1 |
Bardin, L; Cenci, MA; Depoortère, R; Iderberg, H; Kleven, MS; Koek, W; McCreary, AC; Newman-Tancredi, A; Varney, MA | 1 |
Fukuda, K | 1 |
Alonso, V; Anyanwu, EC; Benoit, JL; Ebara, L; Pettit, NN; Wojcik, E | 1 |
Avarello, TP; Cottone, S | 1 |
Bilbao Garay, J; Castilla Castellano, V; Dhimes Tejada, P; Mesa Plaza, N | 1 |
2 review(s) available for levodopa and Serotonin Syndrome
Article | Year |
---|---|
[Dopaminergic treatment in Parkinson's disease: what has each therapeutic family got to offer?].
Topics: Amantadine; Antiparkinson Agents; Cardiovascular Diseases; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Clinical Trials as Topic; Dopamine Agonists; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Food-Drug Interactions; Humans; Indans; Indoles; Levodopa; Mental Disorders; Monoamine Oxidase Inhibitors; Multicenter Studies as Topic; Parkinson Disease; Serotonin Syndrome; Treatment Outcome | 2014 |
[Serotonin syndrome: report of a fatal case and review of the literature].
Topics: Aged; Antiparkinson Agents; Carbidopa; Depressive Disorder, Major; Drug Combinations; Drug Synergism; Fatal Outcome; Fluoxetine; Humans; Levodopa; Male; Parkinson Disease; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin Syndrome | 2002 |
6 other study(ies) available for levodopa and Serotonin Syndrome
Article | Year |
---|---|
Serotonin syndrome following levodopa treatment in diffuse Lewy body disease.
Topics: Diagnosis, Differential; Humans; Levodopa; Lewy Body Disease; Male; Middle Aged; Serotonin Syndrome | 2014 |
Serotonin syndrome in stroke patients.
Topics: Carbidopa; Dopamine Agonists; Drug Combinations; Humans; Indoles; Levodopa; Male; Middle Aged; Serotonin Syndrome; Stroke | 2015 |
NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Brain; Catalepsy; Disease Models, Animal; Drug Interactions; Dyskinesia, Drug-Induced; Female; Haloperidol; Levodopa; Movement; Neurotransmitter Agents; Oxidopamine; Piperidines; Psychomotor Performance; Pyridines; Rats; Rats, Sprague-Dawley; Serotonin 5-HT1 Receptor Agonists; Serotonin Syndrome; Swimming; Vocalization, Animal | 2015 |
Integrated theory to unify status among schizophrenia and manic depressive illness.
Topics: 5-Hydroxytryptophan; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Biopterins; Bipolar Disorder; Blood-Brain Barrier; Depression; Depression, Postpartum; Dopamine; Female; Hallucinations; Humans; Kynurenic Acid; Levodopa; Male; Neuroleptic Malignant Syndrome; Neurotransmitter Agents; Paranoid Disorders; Premenstrual Syndrome; Schizophrenia; Seasonal Affective Disorder; Serotonin; Serotonin Syndrome; Tyrosine | 2015 |
Possible serotonin syndrome with carbidopa-levodopa and linezolid.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Carbidopa; Dopamine Agonists; Drug Combinations; Drug Interactions; Female; Humans; Levodopa; Linezolid; Serotonin Agents; Serotonin Syndrome | 2016 |
Serotonin syndrome: a reported case.
Topics: Aged; Drug Incompatibility; Fatal Outcome; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Serotonin Syndrome | 2002 |